SOLUTIONS · COSMETICS
The signals that move a beauty market move first in conversation.
Texture preferences, ingredient anxiety, generational rituals, a competitor's quiet pivot — they surface in reviews and forums months before they reach a panel report. Reading them early is what separates a category leader from a follower.
What you are navigating.
- Ingredient narratives shift faster than reformulation cycles. A clean-beauty panic, a TikTok molecule, a regulatory tightening — your formulation roadmap was set 18 months ago.
- Specialty retailers and mass markets diverge. What Sephora consumers celebrate, drugstore consumers may distrust — same product, same review, opposite signal.
- Claim wars escalate but evidence requirements do too. Marketing wants louder claims; legal wants defensible ones; consumer reviews are the third voice that arbitrates.
What we bring.
Three concrete capabilities, built specifically for beauty and personal care:
- Future of Ingredients radar. Cross-source signal fusion (consumer reviews, social, search trends, scientific literature, IP filings, public stats) producing weekly ingredient briefs — not aggregations, narratives.
- Aspect-by-aspect product perception. Texture, absorption, scent, efficacy, packaging, value. Decomposed per claim, per segment, per competitor — with the 47 verbatims cited in the artifact.
- Specialty-vs-mass gap diagnostics. Same SKU, two retail contexts. The platform tracks where the perception gap widens and why, before merchandising notices.
INGREDIENT CONSTELLATION · CROSS-SOURCE FUSION
Six molecules. Six sources. Twelve weeks. The pattern emerges.
ANONYMISED · ILLUSTRATIVE · BUBBLE = SIGNAL DENSITY
What changes.
- The ingredient brief lands on the formulation team's desk in days, not quarters.
- Claim defensibility is grounded in lineage — every quote has a source, a date, a model version.
- The next product brief reads like an editorial argument, not a copy of last year's.
- Competitive surveillance is continuous — not an annual offsite slide.
- The CMO walks into Comex with the verbatims that the CFO cannot dismiss.